NCT02941510 is a Phase 3 clinical trial of Budesonide in Altitude Sickness, sponsored by University of Colorado, Denver.

Who is sponsoring NCT02941510?

NCT02941510 is sponsored by University of Colorado, Denver.

What drugs are being tested in NCT02941510?

Interventions in NCT02941510: Budesonide, Placebo.

What condition does NCT02941510 study?

NCT02941510 studies Altitude Sickness.

Is NCT02941510 still recruiting?

NCT02941510 is currently withdrawn. Last updated 13 March 2017.

Last reviewed 2017-03-13 · How we verify

NCT02941510

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inhaled Budesonide for Altitude Illness Prevention

Withdrawn Phase 3 Last updated 13 March 2017

What this trial tests

Phase 3 trial testing Budesonide in Altitude Sickness. Withdrawn.

Timeline

6 March 2017

Primary endpoint
6 March 2017

6 March 2017

Quick facts

Lead sponsor	University of Colorado, Denver
Phase	Phase 3
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Start date	6 March 2017
Primary completion	6 March 2017
Estimated completion	6 March 2017

Drugs / interventions tested

Budesonide (BUDESONIDE) — full drug profile →
Placebo

Conditions studied

Altitude Sickness — all drugs for Altitude Sickness →

Sponsor

University of Colorado, Denver

Who can join

Adults 21 to 40, any sex, with Altitude Sickness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized, double-blinded study administering budesonide, a medication to reduce inflammation in the lungs, to healthy volunteers to examine effects on altitude illness prevention by spending 18 hours overnight at 14,000 ft elevation.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs.
Nieto Estrada VH, Molano Franco D, Medina RD, Gonzalez Garay AG, et al · · 2017 · cited 37× · PMID 28653390 · DOI 10.1002/14651858.cd009761.pub2
Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions.
Molano Franco D, Nieto Estrada VH, Gonzalez Garay AG, Martí-Carvajal AJ, et al · · 2019 · cited 15× · PMID 31012483 · DOI 10.1002/14651858.cd013315
Interventions for preventing high altitude illness: Part 2. Less commonly-used drugs.
Gonzalez Garay A, Molano Franco D, Nieto Estrada VH, Martí-Carvajal AJ, et al · · 2018 · cited 8× · PMID 29529715 · DOI 10.1002/14651858.cd012983

Verify or expand the search:

Other trials of Budesonide

Trials testing the same drug.

NCT07528820 — Inflammatory Profiles, Histopathological Features, and Remodeling Factors in Chronic Rhinosinusitis With Nasal Polyps · NA · not yet recruiting
NCT05878093 — Dupilumab in Chinese Adult Participants With CRSwNP · Phase 3 · completed
NCT05562466 — A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Chil · Phase 3 · recruiting
NCT06268301 — A Study to Determine the Effect Food Has on TAK-721 (Budesonide Oral Suspension) in the Body of Healthy Adults · Phase 1 · completed
NCT05509933 — Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation · Phase 3 · recruiting

Other University of Colorado, Denver trials

Trials by the same sponsor.

NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial. · not yet recruiting
NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity · Phase 3 · not yet recruiting
NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients. · NA · not yet recruiting
NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma · EARLY_PHASE1 · not yet recruiting
NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02941510 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
Last refreshed: 13 March 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02941510.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing